Stouffer Amanda L, Acharya Rudresh, Salom David, Levine Anna S, Di Costanzo Luigi, Soto Cinque S, Tereshko Valentina, Nanda Vikas, Stayrook Steven, DeGrado William F
Department of Biochemistry and Biophysics, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
Nature. 2008 Jan 31;451(7178):596-9. doi: 10.1038/nature06528.
The M2 protein from influenza A virus is a pH-activated proton channel that mediates acidification of the interior of viral particles entrapped in endosomes. M2 is the target of the anti-influenza drugs amantadine and rimantadine; recently, resistance to these drugs in humans, birds and pigs has reached more than 90% (ref. 1). Here we describe the crystal structure of the transmembrane-spanning region of the homotetrameric protein in the presence and absence of the channel-blocking drug amantadine. pH-dependent structural changes occur near a set of conserved His and Trp residues that are involved in proton gating. The drug-binding site is lined by residues that are mutated in amantadine-resistant viruses. Binding of amantadine physically occludes the pore, and might also perturb the pK(a) of the critical His residue. The structure provides a starting point for solving the problem of resistance to M2-channel blockers.
甲型流感病毒的M2蛋白是一种pH激活的质子通道,可介导内体中捕获的病毒颗粒内部的酸化。M2是抗流感药物金刚烷胺和金刚乙胺的作用靶点;最近,人类、鸟类和猪对这些药物的耐药性已超过90%(参考文献1)。在此,我们描述了在存在和不存在通道阻断药物金刚烷胺的情况下,同四聚体蛋白跨膜区域的晶体结构。在一组参与质子门控的保守组氨酸和色氨酸残基附近发生了pH依赖性结构变化。药物结合位点由金刚烷胺耐药病毒中发生突变的残基排列而成。金刚烷胺的结合物理性地阻塞了孔道,也可能扰乱关键组氨酸残基的pK(a)。该结构为解决对M2通道阻滞剂的耐药性问题提供了一个起点。